Bigfoot Biomedical is developing an end-to-end Type 1 Diabetes Management System using simple design, cloud connectivity and human centered automation. Founded by Bryan Mazlish, Jeffrey Brewer, Jon Brilliant, and Lane Desborough in 2014, Bigfoot Biomedical is backed by investors that include Abbott, Cormorant Asset Management, Janus Henderson Investors, Quadrant Capital Advisors, and Abbott Ventures and is headquartered in Milpitas, California.